... the use for CLL patients of Natalizumab (TYSABRI, Biogen Idec, Cambridge, MA andElan Pharmaceuticals, South San Francisco, CA, USA), a humanized anti-CD49d monoclonal antibody alreadyavailable ... Onlus, Novara, Italy; Siena -A. I.L. Onlus, Siena, Italy; Associazione Italiana per la Ricerca sul Cancro (A. I.R.C.), Milan, Italy; Helmut Horten Foundation (Lugano, Swit-zerland); San Salvatore ... 109:2989-2998.91. Murray F, Darzentas N, Hadzidimitriou A, Tobin G, Boudjogra M, Sci-elzo C, Laoutaris N, Karlsson K, Baran-Marzsak F, Tsaftaris A, Moreno C, Anagnostopoulos A, Caligaris-Cappio F, Vaur D,Ouzounis...